SUPRIYA LIFESCIENCE
Back to Balance Sheet
|
SUPRIYA LIFESCIENCE Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,117 Cr | ₹924 Cr | ₹820 Cr | ₹735 Cr | ₹445 Cr |
What is the latest Total Liabilities ratio of SUPRIYA LIFESCIENCE ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,117 Cr |
| Mar2024 | ₹924 Cr |
| Mar2023 | ₹820 Cr |
| Mar2022 | ₹735 Cr |
| Mar2021 | ₹445 Cr |
How is Total Liabilities of SUPRIYA LIFESCIENCE Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,117 Cr | 20.94 | |
| Mar2024 | ₹924 Cr | 12.63 | |
| Mar2023 | ₹820 Cr | 11.64 | |
| Mar2022 | ₹735 Cr | 64.94 | |
| Mar2021 | ₹445 Cr | - | |
Compare Total Liabilities of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹5,550.1 Cr | -3.9% | 8.2% | 3.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | -3.9% |
8.2% |
3.3% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses